
Derivados de Purinas e Pirimidinas
As purinas possuem uma estrutura bicíclica, formada por um anel de seis membros fundido a um anel de cinco membros, ambos contendo átomos de nitrogênio em posições-chave. Os derivados das purinas, como a adenina e a guanina, são essenciais para a formação do DNA e RNA. Estes compostos possuem aplicações terapêuticas no tratamento do câncer e de doenças virais, pois inibem a replicação celular. As pirimidinas, por outro lado, possuem uma estrutura monocíclica de seis membros com dois átomos de nitrogênio. Seus derivados, como citosina, timina e uracila, também são componentes essenciais do DNA e RNA e são utilizados na quimioterapia e em tratamentos antivirais.
Na CymitQuimica, oferecemos derivados de purinas e pirimidinas para pesquisa em biologia molecular, genômica e desenvolvimento de terapias inovadoras.
Foram encontrados 8901 produtos de "Derivados de Purinas e Pirimidinas"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
6-O-Methyl Guanosine
CAS:Produto Controlado<p>Applications A guanine derivative that acts as modulators of GTPases and modulator-resistant enzymes; used in drug design and target validation.<br>References Goth-Goldstein, R., et al.: Cancer Res., 40, 2623 (1980), Nakabeppu, Y., et al.: J. Biol. Chem., 259, 13723 (1984), Modrich, P., et al.: Science, 266, 1959 (1994),<br></p>Fórmula:C11H15N5O5Cor e Forma:WhitePeso molecular:297.27rac Tenofovir-d6
CAS:Produto Controlado<p>Applications A deuterated acyclic phosphonate nucleotide analogue, reverse transcriptase inhibitor. Used as an anti-HIV agent. Antiviral.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997), Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005), Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006), Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007),<br></p>Fórmula:C92H6H8N5O4PCor e Forma:Off White SolidPeso molecular:293.251-Methyluric Acid-d3
CAS:Produto Controlado<p>Applications A labelled metabolite of Theophylline.<br>References Chen, Y., et al.: Clin. Exper. Pharmacol. Physiol., 36, 828 (2009), Yu, C., et al.: J. Bacteriol., 191, 4624 (2009), Jetter, A., et al.: Eur. J. Clin. Pharmacol., 65, 411 (2009),<br></p>Fórmula:C62H3H3N4O3Cor e Forma:NeatPeso molecular:185.161,3-Dimethyluric Acid
CAS:Produto Controlado<p>Applications 1,3-Dimethyluric Acid, is a metabolite of Caffeine (C080100), that is shown to have some of Its similar effects.<br>References Kalow, W., et al.: Clin. Pharmacol. Ther., 53, 503 (1993), Sharma, S., et al.: Cancer Res., 54, 5848 (1994), Sugawara, M., et al.: J. Biol. Chem., 275, 16473 (2000), Takeda, M., et al.: J. Pharmacol. Exp. Ther., 302, 666 (2002),<br></p>Fórmula:C7H8N4O3Cor e Forma:NeatPeso molecular:196.164-(6-BROMOIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-AMINE
CAS:Pureza:95.0%Peso molecular:290.1239929199219Ref: 10-F531136
1gA consultar2gA consultar5gA consultar100mgA consultar250mgA consultar500mgA consultar2-Oxo Clopidogrel Hydrochloride(Mixture of Diastereomers)
CAS:Produto Controlado<p>Applications The essential intermediate metabolite from which the active metabolite of Clopidogel is formed.<br>References Feliste, R., et al.: Thromb. Res., 48, 403 (1987), Savi, P., et al.: Biochem. Pharmacol., 44, 527 (1992), Herbert, J., et al.: Cardiovasc Drug. Rev., 11, 180 (1993), Sugidachi, A., et al.: B. J. Pharmacol., 132, 47 (2001)<br></p>Fórmula:C16H17Cl2NO3SCor e Forma:NeatPeso molecular:374.281-(6-Cyclopropylamino-pyrimidin-4-yl)-piperidine-4-carboxylic acid
CAS:Pureza:95.0%Peso molecular:262.31298828125N-((4,6-dimethoxypyrimidin-2-yl)carbamoyl)-3-(trifluoromethyl)pyridine-2-sulfonamide
CAS:Pureza:98%Cor e Forma:SolidPeso molecular:407.3200073N2-ISOBUTYRYL-2'-O-METHYL-GUANOSINE
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:367.361999511718754-Ethoxy-3-(3-pyridin-2-yl-ureido)benzenesulfonyl chloride
CAS:Fórmula:C14H14ClN3O4SPureza:98%Cor e Forma:SolidPeso molecular:355.791-(4-tert-Butylphenyl)-2-pyrimidin-4-yl ethanol
CAS:Fórmula:C16H20N2OPureza:≥95%Cor e Forma:SolidPeso molecular:256.349(E)-N-(4-(N-(4,6-dimethylpyrimidin-2-yl)sulfamoyl)phenyl)-3-(p-tolyl)acrylamide
CAS:Pureza:98%Peso molecular:422.5Xanthine
CAS:<p>Applications Found in animal organs, yeast, patatoes, coffee beans, tea. This drug can be used to relax and widen certain breathing passages of the lungs. It is also found that a large number of derivatives have adenoside receptor antagonist properties.<br>References Mueller, C. et. al: Handbook Exp. Pharmacol. 200,151(2011)<br></p>Fórmula:C5H4N4O2Cor e Forma:White SolidPeso molecular:152.111-((2R,3R,4S,5S)-3,5-DIFLUORO-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)PYRIMIDINE-2,4(1H,3H)-DIONE
Pureza:90.0%Peso molecular:264.18499755859375Ref: 10-F363409
1gA consultar2gA consultar5gA consultar100mgA consultar250mgA consultar500mgA consultar2-[5-amino-3-(2-furyl)-1H-pyrazol-1-yl]-6-isopropylpyrimidin-4(3H)-one
CAS:Pureza:95.0%Peso molecular:285.3070068359375N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide hydrate
CAS:Pureza:98+%Peso molecular:373.36898803710942-CHLORO-N-(4-CHLOROPHENYL)-9-METHYL-9H-PURIN-6-AMINE
CAS:Pureza:95.0%Peso molecular:294.14001464843754-(2,4-dimethoxyphenyl)-6-(3,4-dimethylphenyl)pyrimidin-2-amine
CAS:Pureza:95.0%Peso molecular:335.40701293945312-Amino-6-(5-methylfuran-2-yl)-5-nitropyrimidin-4-yl 4-methylbenzenesulfonate
CAS:Pureza:97%Peso molecular:390.36999511718754-(3,4-dimethylphenyl)-6-(thiophen-2-yl)pyrimidin-2-amine
CAS:Pureza:95.0%Peso molecular:281.38000488281251-phenyl-5-[(pyrimidin-2-ylsulfanyl)methyl]-1H-1,2,3-triazole-4-carboxylic acid
CAS:Pureza:95.0%Peso molecular:313.3399963378906trans (2,3)-Dihydro Tetrabenazine
CAS:Produto Controlado<p>Applications A metabolite of Tetrabenazine in vivo. The trans izomer of Dihydrotetrabenazine is used for the treatment of hyperkinetic movement disorders.<br>References Kilbourn, M., et al.: Eur. J. Pharmacol., 278, 249 (1995), Perera, R., et al.: J. Med. Chem., 46, 2599 (2003), Mager, D., et al.: J. Pharm. Sci., 94, 2475 (2005), Zheng, G., et al.: Bioorg. Med. Chem., 16, 5018 (2006),<br></p>Fórmula:C19H29NO3Cor e Forma:NeatPeso molecular:319.441-Methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine 1-oxide (Imatinib Impurity)
CAS:Pureza:98%Peso molecular:509.6144-(2-fluorophenyl)-6-(thiophen-2-yl)pyrimidin-2-amine
CAS:Pureza:95.0%Peso molecular:271.309997558593757-Hydroxy Methotrexate Ammonium
CAS:Produto Controlado<p>Applications 7-Hydroxy Methotrexate Ammonium Salt is a metabolite of Methotrexate (M260675), which is used as an antineoplastic and antirheumatic.<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958), Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985),<br></p>Fórmula:C20H22N8O6·NH3Cor e Forma:Yellow To BrownPeso molecular:487.475-cyclopropyl-N-(diaminomethylidene)-1-(quinolin-5-yl)-1H-pyrazole-4-carboxamide
CAS:Pureza:98%Peso molecular:320.3559875488281N-Butyldeoxynojirimycin Hydrochloride
CAS:Produto Controlado<p>Applications An inhibitor of a-glucosidase 1 as well as being an inhibitor of HIV cytopathicity. N-Butyldeoxynojirimycin has recently been used to retard lipid storage in the central nervous system of an animal model of Tay-Sachs disease.1-Deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man.<br>References Hettkamp, H., et al.: Eur. J. Biochem., 142, 85 (1984), Szumilo, T., et al.: Arch. Biochem. Biophys., 247, 261 (1986), Fleet, G.W.J., et al.: FEBS Letters, 237, Number 1,2, 128 (1988), Kolter, T., et al.: Angew. Chem. Int. Ed. Engl., 36, 1955 (1997),<br></p>Fórmula:C10H21NO4·ClHCor e Forma:NeatPeso molecular:255.74Mono-POC Isopropyl Tenofovir(Mixture of Diastereomers)
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Tenofovir (T018500) impurity.<br></p>Fórmula:C17H28N5O7PCor e Forma:White SolidPeso molecular:445.413,5-Dinitropyridine
CAS:Produto Controlado<p>Applications 3,5-Dinitropyridine is used as an azabenzyne pyrolytic precursor. The anion radical of 3,5-dinitropyridine aundergoes reversible dimerization reactions.<br>References Winkler, M., et al.: J. Am. Chem. Soc., 126, 6135 (2004); Macias-Ruvalcaba, N., et al.: J. Electroanal. Chem., 600, 294 (2007)<br></p>Fórmula:C5H3N3O4Cor e Forma:NeatPeso molecular:169.104-Chloro-2-methylpyrimidine-5-carbonitrile
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:153.570007324218754-(4-Oxobutyl)benzoic Acid Methyl Ester
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications 4-(4-Oxobutyl)benzoic Acid Methyl Ester is used as a reagent in the preparation of Pemetrexed (P219500) and furoxanoxyalkyl esters of Pemetrexed as antifolates and nitric oxide donors for use as anticancer agents.<br>References Zhao, D., et al.: Zhongguo Yaowu Huaxue Zazhi, 18, 445 (2008); Yi, B., et al.: Zhongguo Yiyao Gongye Zazhi, 37, 798 (2006); Min, T., et al.: Med. Chem. Res., 18, 495 (2009)<br></p>Fórmula:C12H14O3Cor e Forma:NeatPeso molecular:206.24

